您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Alsterpaullone
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Alsterpaullone
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Alsterpaullone图片
CAS NO:237430-03-4
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
Alsterpaullon (9-Nitropaullone) 是一种有效的 CDK 抑制剂,对 CDK1/cyclin B、CDK2/cyclin A、CDK2/cyclin E 和 CDK5/p35 的 IC50 分别为 35 nM、15 nM、200 nM 和 40 nM。 Alsterpaullon 还与 ATP 竞争结合 GSK-3alpha/GSK-3beta,IC50 均为 4 nM。 Alsterpaullone 具有抗肿瘤活性,并具有研究神经退行性和增殖性疾病的潜力。 Alsterpaullone 在白血病细胞系中诱导细胞凋亡。
Cas No.237430-03-4
别名阿特波龙,9-Nitropaullone,NSC 705701
化学名9-nitro-7,12-dihydrobenzo[2,3]azepino[4,5-b]indol-6(5H)-one
Canonical SMILESO=C1CC2=C(C3=CC=CC=C3N1)NC4=C2C=C(C=C4)[N+]([O-])=O
分子式C16H11N3O3
分子量293.28
溶解度DMF: 3 mg/ml,DMSO: 10 mg/ml,DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Alsterpaullone is a small molecule cyclin-dependent kinase (CDK) inhibitor [1,2].

Cyclin-dependent kinases (CDKs) are protein kinases that play important roles in the control of cell division and modulate transcription in response to several extra- and intracellular cues. Deregulation of CDKs is a hallmark of several diseases, including cancer, and drug-targeted inhibition of specific members has generated very encouraging results in clinical trials [3].

Alsterpaullone (Alp) induced apoptosis and promoted loss in clonogenicity in the Jurkat cell line. Alp activated both caspase-8 and -9, leading to cleavage of caspase-3 and poly (ADP-ribose) polymerase (PARP). Alp disrupted the activation of caspase-9 followed mitochondrial perturbation. Alp activated caspase-9 via mitochondrial perturbation [1]. Alsterpaullone regulated the cell cycle progression. Alsterpaullone inhibited HeLa cells in a time-dependent (0–72 h) and dose-dependent (0–30 μM) manner. Alsterpaullone arrested HeLa cells in G2/M prior to undergoing apoptosis via a mechanism that is involved in the regulation of various antiapoptotic genes, DNA-repair, transcription, and cell cycle progression. Alsterpaullone effectively prevented HeLa cells from entering S-phase [2].

References:
[1] Lahusen T, De Siervi A, Kunick C, et al.  Alsterpaullone, a novel cyclin‐dependent kinase inhibitor, induces apoptosis by activation of caspase‐9 due to perturbation in mitochondrial membrane potential[J]. Molecular carcinogenesis, 2003, 36(4): 183-194.
[2] Cui C, Wang Y, Wang Y, et al.  Alsterpaullone, a cyclin-dependent kinase inhibitor, mediated toxicity in HeLa cells through apoptosis-inducing effect[J]. Journal of analytical methods in chemistry, 2013, 2013.
[3] Malumbres M.  Cyclin-dependent kinases[J]. Genome biology, 2014, 15(6): 122.